Contineum Therapeutics, Inc. Class A CTNM 深 沪
等待开盘 10-16 09:30:00 美东时间
7.90
-0.240
-2.95%
华盛通- 最 高8.56
- 今 开8.25
- 成交量 102.06万股
- 最 低 7.72
- 昨 收 8.14
- 总市值 2.97亿
- 52周最高 17.785
- 市盈率 静 --
- 换手率 2.71%
- 52周最低 7.72
- 委 比 -1.01%
- 总股本 3762.11万
- 历史最高 22.00
- 量 比 0.36
- 振 幅 10.32%
- 历史最低 3.35
- 每 手 1
- 风险率 1.83%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅325.53%！HC Wainwright维持Alector"买入"评级，目标价上调至8美元
今日重点评级关注：HC Wainwright & Co.：维持Alector"买入"评级，目标价从5美元升至8美元；摩根大通：维持ORIC Pharmaceuticals"超配"评级，目标价从23美元升至26美元
10-15 12:36
This Chemours Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst Joel Beatty downgraded Contineum Therapeutics Inc (NASDAQ:CTNM) from Outperform to ...
10-14 21:07
Baird Downgrades Contineum Therapeutics to Neutral, Lowers Price Target to $14
Baird analyst Joel Beatty downgrades Contineum Therapeutics (NASDAQ:CTNM) from Outperform to Neutral and lowers the price target from $19 to $14.
10-14 17:20
Why Is Contineum Therapeutics Stock Falling Monday?
Contineum Therapeutics Inc. (NASDAQ:CTNM) stock plunged Monday following mixed Phase 3 trial results for Bristol Myers Squibb & Co.’s (NYSE:BMY) competing lung disease drug, admilparant. Bristol Myers Squibb reported topline efficacy and safety results from its ALOFT-IPF trial, which evaluated admil...
10-13 00:59
Hewlett Packard Enterprise, Capital Bancorp, FormFactor And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Wednesday. Shares of Hewlett Packard Enterprise Co (NYSE:HPE) rose during Wednesday’s session after the company announced it raised its FY27 networking segment revenue growth guidance. Also, the company announced an order ...
09-30 21:55
美股大行评级 | 潜在涨幅919.61%！HC Wainwright上调NeuroSense Therapeutics目标价至52美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持NeuroSense Therapeutics"买入"评级，目标价从8美元升至52美元；HC Wainwright & Co.：维持艾切托"买入"评级，目标价从27美元升至34美元
09-29 08:33
Morgan Stanley Maintains Equal-Weight on Contineum Therapeutics, Lowers Price Target to $17
Morgan Stanley analyst Jeffrey Hung maintains Contineum Therapeutics (NASDAQ:CTNM) with a Equal-Weight and lowers the price target from $18 to $17.
09-28 21:06
美股大行评级 | 巴克莱大幅升Strategy目标价至160美元！康宁遭看淡至180美元，较现价仍溢价25%
今日重点评级关注：HC Wainwright & Co.：上调Cardiff Oncology评级至"买入"，目标价9美元；古根海姆：维持Inventiva"买入"评级，目标价从11美元升至14美元
09-16 16:10
Johnson & Johnson Partner Contineum Slides as Depression Drug Fails
Contineum Therapeutics, Inc. (NASDAQ:CTNM) shares are trading lower on Tuesday as Phase 2 results from a key study disappoint. The pullback lines up with a risk-off tone in futures, but the company-specific clinical update appears to be the main driver. CTNM Stock Drops After Phase 2 MOONLIGHT-1 Res...
09-15 23:07
Contineum’s Phase 2 MOONLIGHT-1 Trial Of JNJ-5120/PIPE-307 Did Not Meet Its Primary Efficacy Endpoint; Analyses Of The Data, Including Prespecified Exploratory Endpoints, Are Ongoing
Phase 2 MOONLIGHT-1 trial did not meet its primary efficacy endpoint Analyses of the data, including prespecified exploratory endpoints, are ongoing Contineum Therapeutics, Inc. (NASDAQ:CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated small molec...
09-15 04:09
